Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.810
+0.020 (1.12%)
At close: Mar 28, 2025, 4:00 PM
1.821
+0.011 (0.60%)
After-hours: Mar 28, 2025, 7:53 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $129.98 million as of March 28, 2025. Its market cap has decreased by -88.07% in one year.
Market Cap
129.98M
Enterprise Value
-198.46M
1-Year Change
-88.07%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has increased from $129.95M to $129.98M, an increase of 0.02%. That is a compound annual growth rate of 0.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 129.98M | -39.81% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 1,523.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 740.72B |
| UnitedHealth Group | 475.20B |
| Johnson & Johnson | 394.70B |
| AbbVie | 358.94B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 228.52B |
| AstraZeneca | 225.00B |
| Merck & Co. | 224.29B |